On March 5, 2026, the Food and Drug Administration approved teclistamab (Tecvayli, Janssen Biotech, Inc.) in combination with daratumumab hyaluronidase-fihj for adult patients with relapsed or refractory […]
Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Recipient: Premium Health Management Inc. dba Premium Health 1800 E. Garry Ave. Suite 224Santa Ana, CA […]
PHILADELPHIA — The investigational drug navenibart reduced attacks of hereditary angioedema by an average 91% over 1 year with only twice-yearly dosing and no serious adverse […]
For Immediate Release: March 05, 2026 The U.S. Food and Drug Administration today issued a Request for Information (RFI) seeking public comment on potential new standards […]
Adhering to a healthy diet could reduce the risk for premature aging among adult survivors of childhood cancer, according to a recent report from the St. […]
Chronic rhinosinusitis may be linked to an increased risk for cancer, according to a study of patients in Asia. The study found that chronic rhinosinusitis was […]
TOPLINE: Lobectomy was associated with oncologic outcomes comparable to those of total thyroidectomy in patients with sporadic medullary thyroid cancer. Mortality, biochemical cure (serum calcitonin levels […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.